QuidelOrtho Corporation
QDEL
$14.78
-$0.82-5.26%
NASDAQ
| 12/28/2025 | 09/28/2025 | 06/29/2025 | 03/30/2025 | 12/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 723.60M | 699.90M | 613.90M | 692.80M | 707.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 723.60M | 699.90M | 613.90M | 692.80M | 707.80M |
| Cost of Revenue | 401.90M | 362.80M | 339.00M | 349.50M | 381.70M |
| Gross Profit | 321.70M | 337.10M | 274.90M | 343.30M | 326.10M |
| SG&A Expenses | 194.40M | 186.90M | 180.70M | 187.00M | 187.50M |
| Depreciation & Amortization | 45.60M | 47.70M | 47.90M | 48.00M | 47.90M |
| Other Operating Expenses | 6.90M | 14.30M | 5.10M | 6.40M | -3.60M |
| Total Operating Expenses | 694.60M | 653.20M | 618.40M | 644.10M | 660.80M |
| Operating Income | 29.00M | 46.70M | -4.50M | 48.70M | 47.00M |
| Income Before Tax | -112.40M | -756.90M | -229.60M | -8.80M | -140.90M |
| Income Tax Expenses | 18.30M | -23.90M | 25.80M | 3.90M | 37.50M |
| Earnings from Continuing Operations | -130.70M | -733.00M | -255.40M | -12.70M | -178.40M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -130.70M | -733.00M | -255.40M | -12.70M | -178.40M |
| EBIT | 29.00M | 46.70M | -4.50M | 48.70M | 47.00M |
| EBITDA | 137.90M | 158.80M | 105.80M | 155.80M | 153.60M |
| EPS Basic | -1.92 | -10.78 | -3.77 | -0.19 | -2.65 |
| Normalized Basic EPS | -0.16 | 0.00 | -0.49 | 0.07 | 0.06 |
| EPS Diluted | -1.92 | -10.78 | -3.77 | -0.19 | -2.66 |
| Normalized Diluted EPS | -0.16 | 0.00 | -0.49 | 0.07 | 0.06 |
| Average Basic Shares Outstanding | 68.00M | 68.00M | 67.70M | 67.50M | 67.30M |
| Average Diluted Shares Outstanding | 68.00M | 68.00M | 67.70M | 67.50M | 67.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |